Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact

Epigenetic silencing of EVL/miR-342 in multiple myeloma

(2018) Zhenhai Li et al.   Translational Research

Epigenetic silencing of LPP/miR-28 in multiple myeloma

(2017) Zhenhai Li et al.   JOURNAL OF CLINICAL PATHOLOGY

Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation

(2017) J Xu et al.   Oncogenesis

Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management

(2016) S. Vincent Rajkumar   AMERICAN JOURNAL OF HEMATOLOGY

MicroRNA-340 Induces Apoptosis and Inhibits Metastasis of Ovarian Cancer Cells by Inactivation of NF-κB1

(2016) Peiquan Li et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma

(2016) Y Qin et al.   LEUKEMIA

miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis

(2016) Tingting Huang et al.   Molecular Cancer

miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS

(2016) Danilo Fiore et al.   Oncotarget

miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2

(2015) Xuesong Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

(2015) Brian A. Walker et al.   JOURNAL OF CLINICAL ONCOLOGY

miRWalk2.0: a comprehensive atlas of microRNA-target interactions

(2015) Harsh Dweep et al.   NATURE METHODS

MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway

(2015) KAI HUANG et al.   ONCOLOGY REPORTS

DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma

(2015) Kwan Yeung Wong et al.   Epigenomics

miRNAs in multiple myeloma – a survival relevant complex regulator of gene expression

(2015) Anja Seckinger et al.   Oncotarget

Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation

(2015) Marta Lionetti et al.   Oncotarget

Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

(2015) Robert A. Kyle et al.   JAMA Oncology

Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy

(2014) Jens G. Lohr et al.   CANCER CELL

miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway

(2014) Jian-Jun Zhao et al.   CANCER RESEARCH

MicroRNAs in hematological malignancies

(2013) Charles H. Lawrie   BLOOD REVIEWS

Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL

(2013) Kwan Wong et al.   Cancer Cell International

Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth

(2013) E. Leone et al.   CLINICAL CANCER RESEARCH

Epigenetic inactivation of the MIR129-2 in hematological malignancies

(2013) Kwan-Yeung Wong et al.   Journal of Hematology & Oncology

Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia - implications on constitutive activation of NFκB pathway

(2013) Lu Wang et al.   Molecular Cancer

Down-regulation of miR-517a and miR-517c promotes proliferation of hepatocellular carcinoma cells via targeting Pyk2

(2012) Rui-Fang Liu et al.   CANCER LETTERS

Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD

(2012) Chor Chim et al.   Journal of Hematology & Oncology

Epigenetic inactivation of the MIR34B/C in multiple myeloma

(2011) K. Y. Wong et al.   BLOOD

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

(2011) S. V. Rajkumar et al.   BLOOD

Epigenetic silencing of MIR203 in multiple myeloma

(2011) Kwan-Yeung Wong et al.   BRITISH JOURNAL OF HAEMATOLOGY

miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met

(2011) Zheng-sheng Wu et al.   CANCER

Initial genome sequencing and analysis of multiple myeloma

(2011) Michael A. Chapman et al.   NATURE

DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer

(2011) P Lopez-Serra et al.   ONCOGENE

Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies

(2011) Kwan Yeung Wong et al.   PLoS One

Epigenetic inactivation of the miR-34a in hematological malignancies

(2010) C.S. Chim et al.   CARCINOGENESIS

Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients

(2010) Chor Chim   Journal of Translational Medicine

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles

(2009) Marta Lionetti et al.   GENES CHROMOSOMES & CANCER

Impact of XIAP protein levels on the survival of myeloma cells

(2008) G. Desplanques et al.   HAEMATOLOGICA